Floatz logo

Inulin

Antibiotic Resistant Infection

Columbia Universityother_biologicalPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Antibiotic Resistant Infection cohort.

Asset / SponsorPhaseRating
POLY(ACETYL, ARGINYL)GLUCOSAMINE (25000-50000 MW)
Synspira, Inc.
Phase 1CC
L-Ofloxacin
Jessa Hospital
N/AD

Same molecule, other indications

Inulin is also rated in:

DysbiosisDormant
BB
Indicative ·
69 / 100
View asset →
cystic fibrosisDormant
B
Indicative ·
62 / 100
View asset →
Obesity, AbdominalDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →